Journal of cannabis research

J Cannabis Res · ISSN (e) 2522-5782 · 8 papers in corpus
2025
doi:10.1186/s42238-025-00344-1 ·PMID:41233935

BACKGROUND: Since its initial approval in 1992, medical cannabis (MC) in Israel has undergone extensive regulatory and structural transformation. This study aims to present the most comprehensive retrospective analysis to date of the evolvi…

other 2025
doi:10.1186/s42238-025-00275-x ·PMID:40442827

BACKGROUND: Endocannabinoids are small lipid molecules that have critical roles in cellular proliferation and function. They are produced locally with their concentrations controlled via the endocannabinoid system (ECS). The important cellu…

2024
doi:10.1186/s42238-024-00230-2 ·PMID:38600591

BackgroundMedical cannabis, legalized in many countries, remains illegal in France. Despite an experiment in the medical use of cannabis that began in March 2021 in France, little is known about the factors associated with the use of cannab…

2023
doi:10.1186/s42238-023-00186-9 ·PMID:37312194

The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention, with speculation that CBD can be useful in a wide range of conditions. Only one product, a purified form of plant-derived CBD in solution (Epidiolex)…

2022
doi:10.1186/s42238-022-00135-y ·PMID:35619155

ObjectiveCannabis is increasingly used for medical purposes, particularly in countries like Canada where cannabis was recently legalized for recreational use. We aimed to assess self-medication with cannabis post-cannabis legalization among…

review 2022
doi:10.1186/s42238-022-00163-8 ·PMID:36207747

Endometriosis patients experience debilitating chronic pain, and the first-line treatment is ineffective at managing symptoms. Although surgical removal of the lesions provides temporary relief, more than 50% of the patients experience dise…

2021
doi:10.1186/s42238-021-00060-6 ·PMID:33597032

BackgroundThe use of cannabis for treating fibromyalgia syndrome (FMS) has not been comprehensively investigated. Thus, we have assessed the efficacy and adverse events (AEs) of short- and long-term medical cannabis (MC) treatment for FMS.M…

2021
doi:10.1186/s42238-021-00061-5 ·PMID:33602344

BackgroundPublic and medical interest in cannabidiol (CBD) has been rising, and CBD is now available from various sources. Research into the effects of low-dose CBD on outcomes like stress, anxiety, and sleep problems have been scarce, so w…